Treatment with Injectable Platelet-Rich Fibrin in a Rat Model of Melasma
October 2023
in “
European journal of dermatology/EJD. European journal of dermatology
”
Studysummary In this study, I-PRF, a blood-derived biomaterial without anticoagulants, was found to inhibit melanin production and reduce oxidative stress damage in a rat model of melasma, suggesting it as a safe and cost-effective treatment option.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer